1. Home
  2. Pharma & Healthcare
  3. Global Cancer Medication Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Cancer Medication Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 134 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Cancer Medication market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Cancer Medication market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Cancer Medication in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Antimetabolite
Alkaloid Drugs
Hormone
Targeted Drug
Platinum-based Drugs
Other

Market Snapshot, By Application
Blood Cancer
Breast Cancer
Castrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Sanofi
Roche
QILU
Novartis
LUYE
Lunan
HENGRUI
HANSOH
GuiZhou YiBai
Eli Lilly and Company
AstraZeneca

The study objectives of this report are:
To study and analyze the global Cancer Medication market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Cancer Medication market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Cancer Medication manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Medication market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Cancer Medication submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cancer Medication are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Cancer Medication Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Cancer Medication Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Cancer Medication

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Cancer Medication Sales Channel and Distributors Analysis
3.3.1 Cancer Medication Sales Channel
3.3.2 Cancer Medication Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Cancer Medication Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Cancer Medication Type Introduction
4.1.1 Antimetabolite
4.1.2 Alkaloid Drugs
4.1.3 Hormone
4.1.4 Targeted Drug
4.1.5 Platinum-based Drugs
4.1.6 Other
4.2 Global Cancer Medication Sales by Type 2016-2021
4.3 Global Cancer Medication Revenue by Type 2016-2021
4.4 Global Cancer Medication Price by Type 2016-2021

5 Market Segment: by Application
5.1 Cancer Medication Type Introduction
5.1.1 Blood Cancer
5.1.2 Breast Cancer
5.1.3 Castrointestinal Cancer
5.1.3 Prostate Cancer
5.1.4 Respiratory/Lung Cancer
5.1.5 Other
5.2 Global Cancer Medication Sales by Application 2016-2021
5.3 Global Cancer Medication Revenue by Application 2016-2021
5.4 Global Cancer Medication Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Cancer Medication Market by Region
6.1.1 Global Cancer Medication Sales by Regions
6.1.2 Global Cancer Medication Revenue by Regions
6.2 North America Cancer Medication Market 2016-2021
6.3 Europe Cancer Medication Market 2016-2021
6.4 Asia Pacific Cancer Medication Market 2016-2021
6.5 South America Cancer Medication Market 2016-2021
6.6 Middle East and Africa Cancer Medication Market 2016-2021

7 North America
7.1 North America Cancer Medication Market by Country 2016-2021
7.1.1 North America Cancer Medication Sales by Country
7.1.2 North America Cancer Medication Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Cancer Medication Market by Country 2016-2021
8.1.1 Europe Cancer Medication Sales by Country
8.1.2 Europe Cancer Medication Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Cancer Medication Market by Country 2016-2021
9.1.1 Asia Pacific Cancer Medication Sales by Country
9.1.2 Asia Pacific Cancer Medication Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Cancer Medication Market by Country 2016-2021
10.1.1 South America Cancer Medication Sales by Country
10.1.2 South America Cancer Medication Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Cancer Medication Market by Country 2016-2021
11.1.1 Middle East and Africa Cancer Medication Sales by Country
11.1.2 Middle East and Africa Cancer Medication Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Cancer Medication Product Portfolio, Specification and Application
12.1.3 Sanofi Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Sanofi Key Development
12.2 Roche
12.2.1 Roche Company Information
12.2.2 Roche Cancer Medication Product Portfolio, Specification and Application
12.2.3 Roche Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Roche Key Development
12.3 QILU
12.3.1 QILU Company Information
12.3.2 QILU Cancer Medication Product Portfolio, Specification and Application
12.3.3 QILU Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 QILU Key Development
12.4 Novartis
12.4.1 Novartis Company Information
12.4.2 Novartis Cancer Medication Product Portfolio, Specification and Application
12.4.3 Novartis Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Novartis Key Development
12.5 LUYE
12.5.1 LUYE Company Information
12.5.2 LUYE Cancer Medication Product Portfolio, Specification and Application
12.5.3 LUYE Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 LUYE Key Development
12.6 Lunan
12.6.1 Lunan Company Information
12.6.2 Lunan Cancer Medication Product Portfolio, Specification and Application
12.6.3 Lunan Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Lunan Key Development
12.7 HENGRUI
12.7.1 HENGRUI Company Information
12.7.2 HENGRUI Cancer Medication Product Portfolio, Specification and Application
12.7.3 HENGRUI Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Lunan Key Development
12.9 GuiZhou YiBai
12.9.1 GuiZhou YiBai Company Information
12.9.2 GuiZhou YiBai Cancer Medication Product Portfolio, Specification and Application
12.9.3 GuiZhou YiBai Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 GuiZhou YiBai Key Development
12.8 HANSOH
12.8.1 HANSOH Company Information
12.8.2 HANSOH Cancer Medication Product Portfolio, Specification and Application
12.8.3 HANSOH Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 HANSOH Key Development
12.11 AstraZeneca
12.11.1 AstraZeneca Company Information
12.11.2 AstraZeneca Cancer Medication Product Portfolio, Specification and Application
12.11.3 AstraZeneca Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 AstraZeneca Key Development

13 Global Cancer Medication Market Forecast by Region by Type and by Application
13.1 Global Cancer Medication Sales, Revenue Forecast 2022-2027
13.2 Global Cancer Medication Forecast by Regions
13.2.1 Global Cancer Medication Sales Forecast by Region 2022-2027
13.2.2 Global Cancer Medication Revenue Forecast by Region 2022-2027
13.3 Global Cancer Medication Forecast by Type
13.3.1 Global Cancer Medication Sales Forecast by Type 2022-2027
13.3.2 Global Cancer Medication Revenue Forecast by Type 2022-2027
13.3.3 Global Cancer Medication Price Forecast by Type 2022-2027
13.4 Global Cancer Medication Forecast by Application
13.4.1 Global Cancer Medication Sales Forecast by Application 2022-2027
13.4.2 Global Cancer Medication Revenue Forecast by Application 2022-2027
13.4.3 Global Cancer Medication Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Cancer Medication Production Specifications
Table 2: Drivers in Cancer Medication Market
Table 3: Restraints Cancer Medication Market
Table 4: Opportunity in Cancer Medication Market
Table 5: Comparion of Alternative and Cancer Medication
Table 6: Cancer Medication Raw Materials Key Suppliers List
Table 7: Cancer Medication Distributors List
Table 8: Cancer Medication Major Buyers in Application One
Table 9: Cancer Medication Major Buyers in Application Two
Table 10: Cancer Medication Major Buyers in Application Three
Table 11: Global Cancer Medication Sales (K Units) by Type 2016-2021
Table 12: Global Cancer Medication Sales Market Share by Type 2016-2021
Table 13: Global Cancer Medication Revenue (Million USD) by Type 2016-2021
Table 14: Global Cancer Medication Revenue Market Share by Type 2016-2021
Table 15: Global Cancer Medication Price by Type 2016-2021
Table 16: Global Cancer Medication Sales (K Units) by Application 2016-2021
Table 17: Global Cancer Medication Sales Market Share by Application 2016-2021
Table 18: Global Cancer Medication Revenue (Million USD) by Application 2016-2021
Table 19: Global Cancer Medication Revenue Market Share by Application 2016-2021
Table 20: Global Cancer Medication Price by Application 2016-2021
Table 21: Global Cancer Medication Sales (K Units) by Region 2016-2021
Table 22: Global Cancer Medication Sales Market Share by Region 2016-2021
Table 23: Global Cancer Medication Revenue (Million USD) by Region 2016-2021
Table 24: Global Cancer Medication Revenue Market Share by Region 2016-2021
Table 25: North America Cancer Medication Sales (K Units) by Country 2016-2021
Table 26: North America Cancer Medication Sales Market Share by Country 2016-2021
Table 27: North America Cancer Medication Revenue (Million USD) by Country 2016-2021
Table 28: North America Cancer Medication Revenue Market Share by Country 2016-2021)
Table 29: Europe Cancer Medication Sales (K Units) by Country 2016-2021
Table 30: Europe Cancer Medication Sales Market Share by Country 2016-2021
Table 31: Europe Cancer Medication Revenue (Million USD) by Country 2016-2021
Table 32: Europe Cancer Medication Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Cancer Medication Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Cancer Medication Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Cancer Medication Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Cancer Medication Revenue Market Share by Country 2016-2021)
Table 37: South America Cancer Medication Sales (K Units) by Country 2016-2021
Table 38: South America Cancer Medication Sales Market Share by Country 2016-2021
Table 39: South America Cancer Medication Revenue (Million USD) by Country 2016-2021
Table 40: South America Cancer Medication Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Cancer Medication Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Cancer Medication Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Cancer Medication Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Cancer Medication Revenue Market Share by Country 2016-2021)
Table 45 Sanofi Company Information
Table 46 Sanofi Cancer Medication Product Portfolio, Specification and Application
Table 47 Sanofi Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Roche Company Information
Table 49 Roche Cancer Medication Product Portfolio, Specification and Application
Table 50 Roche Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 QILU Company Information
Table 52 QILU Cancer Medication Product Portfolio, Specification and Application
Table 53 QILU Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Novartis Company Information
Table 55 Novartis Cancer Medication Product Portfolio, Specification and Application
Table 56 Novartis Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 LUYE Company Information
Table 58 LUYE Cancer Medication Product Portfolio, Specification and Application
Table 59 LUYE Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Lunan Company Information
Table 61 Lunan Cancer Medication Product Portfolio, Specification and Application
Table 62 Lunan Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 HENGRUI Company Information
Table 64 HENGRUI Cancer Medication Product Portfolio, Specification and Application
Table 65 HENGRUI Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 HANSOH Company Information
Table 67 HANSOH Cancer Medication Product Portfolio, Specification and Application
Table 68 HANSOH Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 GuiZhou YiBai Company Information
Table 70 GuiZhou YiBai Cancer Medication Product Portfolio, Specification and Application
Table 71 GuiZhou YiBai Cancer Medication Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Cancer Medication Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Cancer Medication Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Cancer Medication Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Cancer Medication Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Cancer Medication Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Cancer Medication Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Cancer Medication Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Cancer Medication Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Cancer Medication Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Cancer Medication Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Cancer Medication Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Cancer Medication Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Cancer Medication Picture
Figure 2: Global Cancer Medication Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Cancer Medication Supply Chain Analysis
Figure 5: Cancer Medication Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Antimetabolite
Figure 7: Product Picture of Alkaloid Drugs
Figure 8: Global Cancer Medication Sales Market Share by Type, 2020
Figure 9: Global Cancer Medication Revenue Market Share by Type, 2020
Figure 10: Cancer Medication in Blood Cancer
Figure 11: Global Cancer Medication Market: Blood Cancer 2016-2021
Figure 12: Cancer Medication in Breast Cancer
Figure 13: Global Cancer Medication Market: Breast Cancer 2016-2021
Figure 14: Global Cancer Medication Sales Market Share by Application, 2020
Figure 15: Global Cancer Medication Revenue Market Share by Application, 2020
Figure 16: Global Cancer Medication Sales Market Share by Region 2016-2021
Figure 17: Global Cancer Medication Revenue Market Share by Region 2016-2021
Figure 18: North America Cancer Medication Sales (K Units) Status 2016-2021
Figure 19: North America Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 20: Europe Cancer Medication Sales (K Units) Status 2016-2021
Figure 21: Europe Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Cancer Medication Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 24: South America Cancer Medication Sales (K Units) Status 2016-2021
Figure 25: South America Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Cancer Medication Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 28: North America Cancer Medication Sales Market Share by Country, 2020
Figure 29: North America Cancer Medication Revenue Market Share by Country, 2020
Figure 30: United States Cancer Medication Sales (K Units) Status 2016-2021
Figure 31: United States Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 32: Canada Cancer Medication Sales (K Units) Status 2016-2021
Figure 33: Canada Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Cancer Medication Sales (K Units) Status 2016-2021
Figure 35: Mexico Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 36: Europe Cancer Medication Sales Market Share by Country, 2020
Figure 37: Europe Cancer Medication Revenue Market Share by Country, 2020
Figure 38: Germany Cancer Medication Sales (K Units) Status 2016-2021
Figure 39: Germany Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 40: France Cancer Medication Sales (K Units) Status 2016-2021
Figure 41: France Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 42: UK Cancer Medication Sales (K Units) Status 2016-2021
Figure 43: UK Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 44: Italy Cancer Medication Sales (K Units) Status 2016-2021
Figure 45: Italy Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 46: Russia Cancer Medication Sales (K Units) Status 2016-2021
Figure 46: Russia Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 47: Spain Cancer Medication Sales (K Units) Status 2016-2021
Figure 48: Spain Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Cancer Medication Sales Market Share by Country, 2020
Figure 50: Asia Pacific Cancer Medication Revenue Market Share by Country, 2020
Figure 51: China Cancer Medication Sales (K Units) Status 2016-2021
Figure 52: China Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 53: Japan Cancer Medication Sales (K Units) Status 2016-2021
Figure 54: Japan Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 55: Korea Cancer Medication Sales (K Units) Status 2016-2021
Figure 56: Korea Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Cancer Medication Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 59: India Cancer Medication Sales (K Units) Status 2016-2021
Figure 60: India Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 61: Australia Cancer Medication Sales (K Units) Status 2016-2021
Figure 62: Australia Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 63: South America Cancer Medication Sales Market Share by Country, 2020
Figure 64: South America Cancer Medication Revenue Market Share by Country, 2020
Figure 65: Brazil Cancer Medication Sales (K Units) Status 2016-2021
Figure 66: Brazil Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Cancer Medication Sales (K Units) Status 2016-2021
Figure 68: Argentina Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Cancer Medication Sales (K Units) Status 2016-2021
Figure 70: Colombia Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Cancer Medication Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Cancer Medication Revenue Market Share by Country, 2020
Figure 73: Turkey Cancer Medication Sales (K Units) Status 2016-2021
Figure 74: Turkey Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Cancer Medication Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Cancer Medication Sales (K Units) Status 2016-2021
Figure 78: South Africa Cancer Medication Revenue (Million USD) Status 2016-2021
Figure 79: Sanofi Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 80: Roche Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 81: QILU Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 82: Novartis Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 83: LUYE Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 84: Lunan Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 85: HENGRUI Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 86: HANSOH Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 87: GuiZhou YiBai Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 88: Eli Lilly and Company Cancer Medication Revenue Market Share Globally (2019-2021)
Figure 89: Global Cancer Medication Sales (K Units) Forecast (2022-2027)
Figure 90: Global Cancer Medication Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets